No Data
Select Medical Holdings Corporation to Announce Third Quarter 2024 Results on Thursday, October 31, 2024
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
Select Medical Holdings Corporation's (NYSE:SEM) Business Is Trailing The Market But Its Shares Aren't
Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target
Benchmark Co. Maintains Select Medical Holdings(SEM.US) With Buy Rating, Maintains Target Price $48
Benchmark Co. analyst Bill Sutherland maintains $Select Medical Holdings(SEM.US)$ with a buy rating, and maintains the target price at $48.According to TipRanks data, the analyst has a success rate
Select Medical Didn't Disclose Terms of Purchase >SEM